Quad M Solutions Inc. Signs MOU with Quantum Computing Inc.
Will Deliver the First Quantum Solution for Medical Underwriting Edgewater, NJ, Jan. 19, 2022 (GLOBE NEWSWIRE) -- Quad M solutions,...
Day: January 19, 2022
FDA Agrees to Use of New Higher-Yielding Manufacturing Process for Nomacopan in Pivotal Clinical Studies
New manufacturing process increases the final yield of nomacopan by at least 5-fold thereby significantly lowering the cost of goods...
ChemoCentryx Announces EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated Vasculitis
-- Launch Expected in H1 2022 -- SAN CARLOS, Calif., Jan. 19, 2022 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI),...
Outlook Therapeutics to Present at the Virtual Investor 2022 Top Picks Conference
Live video webcast presentation on Tuesday, January 25th at 3:00 PM ETISELIN, N.J., Jan. 19, 2022 (GLOBE NEWSWIRE) -- Outlook...
Spero Therapeutics Awarded up to an Additional $12.9 Million by BARDA to Support the Development of Orally Administered Tebipenem Pivoxil in Pediatric Patients
New award option exercised by BARDA brings the total potential funding from its existing contract with Spero up to $59.7...
Pepperdine University Hosts the 22nd Annual Celebrity Flag Football Challenge®, Presented by Todos Medical’s Tollovid®
In support of First Responders, Military Service Members and Boys and Girls Youth Groups MALIBU, CALIFORNIA, Jan. 19, 2022 (GLOBE...
CytomX Therapeutics Announces FDA Clearance of Investigational New Drug Application for CX-904 for the Treatment of Advanced Solid Tumors
- CX-904 is CytomX’s first T-cell-engaging bispecific antibody and the sixth Probody® therapeutic candidate to enter the clinic -SOUTH SAN...
DLH to Announce First Quarter FY22 Financial Results
ATLANTA, Jan. 19, 2022 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading healthcare and...
PepGen Appoints Laurie Keating as Chair of Board of Directors
Keating brings strong experience as a life science executive and Board memberBOSTON, Jan. 19, 2022 (GLOBE NEWSWIRE) -- PepGen, Inc., a...
M Health Fairview University of Minnesota Medical Center Receives First Hyperfine Portable MRI to Grow its Advanced Imaging Systems Offering
World’s first FDA-cleared portable MRI expands leading neurosurgery suite’s tech capabilities for novel diagnostic and therapeutic approachesGUILFORD, Conn. and MINNEAPOLIS,...
SmileDirectClub Expands Oral Care Line With Launch Of Innovative New Fast-Dissolving Whitening Strips
Leading Oral Care Company Has Teamed with Peloton Star Tunde Oyeneyin to Promote the Power of a Bright and Healthy...
Recce Pharmaceuticals Announces Positive Safety Data from Second Cohort of Phase I Clinical Trial Evaluating Healthy Subjects Intravenously Dosed with RECCE® 327
Highlights: Seven subjects in cohort two intravenously dosed with RECCE® 327 (R327) at 150mg met all endpoints - indicating R327...
HCW Biologics’ Founder and CEO Dr. Hing C. Wong Participating in Cambridge Healthtech Institute’s Annual PepTalk Conference 2022
A Novel Platform to Create Multi-Functional Immunotherapeutics for Cancer Will Feature TOBI™ Discovery Platform and Lead Product Candidate, HCW9218MIRAMAR, Fla.,...
VYNE Therapeutics Announces Phase 1b Data for FMX114 from Phase 1b/2a Trial for the Treatment of Mild-to-Moderate Atopic Dermatitis
Systemic bioavailability of JAK inhibitor (tofacitinib) and S1P receptor modulator (fingolimod) in topical formulation substantially lower compared to oral equivalents...
LifeMD Provides Initial FY2022 Guidance and Announces Preliminary FY2021 Revenues
Total FY2022 revenue anticipated to be in the range of $142 to $148 million Remains on track to achieve Adjusted...
X4 Pharmaceuticals to Present at B. Riley Securities Oncology Investor Conference
BOSTON, Jan. 19, 2022 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of...
ImmixBio Announces Positive IMX-110 Phase 1b/2a Interim Clinical Trial Safety Data Demonstrating 100% Completion of Planned Treatment Cycles
100% of Patients On IMX-110 Completed Planned Treatment Cycles Immix Biopharma, Inc. (NASDAQ:IMMX) 100% of patients treated with IMX-110 completed...
InMed Launches Cannabicitran (CBT), Expanding its Rare Cannabinoid Portfolio for the Health and Wellness Sector
CBT is the first of several rare cannabinoid launches planned for the first half of 2022; includes CBDV and THCVExpands...
Yumanity Reports Partial Clinical Hold by U.S. FDA on Multidose Clinical Trials for YTX-7739
BOSTON, Jan. 19, 2022 (GLOBE NEWSWIRE) -- Yumanity Therapeutics (Nasdaq: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development...
Vivos Therapeutics Announces 18X Increase in Sleep Apnea Diagnostic Testing By Vivos Dentists Using SleepImage Technology
Vivos Also Announces Improved Pricing Agreement With SleepImage Dentists and Patients Report Exceptional User Experience with SleepImage Home Sleep Test...
